Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corporation, known as Amwell (NYSE: AMWL), regularly issues news and updates about its role in digital care and technology-enabled healthcare. Company announcements highlight its SaaS-based care platform, relationships with payers, health systems and government organizations, and its ongoing work to support digital and hybrid care models.
On this news page, readers can follow Amwell’s earnings announcements and quarterly operating updates, which are often accompanied by investor conference calls and webcasts. The company frequently reports the timing of its financial results, provides access details for live audio webcasts and notes the availability of replay links through its investor resources.
Amwell’s news flow also covers commercial partnerships and contracts. For example, the company has reported on its role in the U.S. Defense Health Agency’s Digital First Program for the Military Health System, where its technology-enabled care platform powers virtual visits integrated with the MHS GENESIS electronic health record. News items describe how the platform supports military care teams, service members and their families across the global Department of Defense enterprise.
Investors and observers can also see updates on Amwell’s agreements with Elevance Health related to the LiveHealth Online white‑label digital care platform, as well as disclosures about equity inducement grants to new employees under its inducement plan. Together, these items provide insight into Amwell’s operational priorities, customer relationships and use of technology to support digital care programs.
For anyone tracking AMWL, this news feed brings together company-issued releases on financial results, major contracts, investor conference participation and corporate actions, offering a centralized view of Amwell’s public communications about its technology-enabled care business.
Amwell (NYSE: AMWL), a leader in digital care delivery, will report its second quarter results for the period ending June 30, 2022, on Thursday, August 4, 2022. The management team will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the results and provide updates. Investors can access the webcast on the Amwell website or listen via phone. Amwell connects providers, insurers, and patients to enhance access to affordable healthcare, serving over 2,000 hospitals and 55 health plans worldwide.
Amwell (NYSE: AMWL) has appointed Dr. Carrie Nelson as its new Chief Medical Officer, bringing over 28 years of experience in Family Medicine and population health. Dr. Nelson aims to enhance clinical and operational outcomes for provider and payer organizations through Amwell's digital care delivery platform, Converge™. Previously, she served as Senior Vice President and CMO at Advocate Aurora Health. COO Kurt Knight emphasized her clinical background will be instrumental in advancing Amwell's sales, implementation, and quality metrics within the hybrid healthcare landscape.
Amwell (NYSE: AMWL) has announced a deal to shorten the earnout period from its August 2021 acquisition of SilverCloud Health, a digital mental health company. This restructuring leads to the issuance of 4,959,856 shares of Class A common stock to SilverCloud's former stockholders. The move aims to expedite the integration of SilverCloud into Amwell’s platform, which Dr. Ido Schoenberg highlights as pivotal for enhancing cultural and operational efficiency in delivering behavioral health solutions. The partnership expects to address the significant demand in behavioral health care exacerbated by recent global events.
Amwell reported Q1 2022 revenue of $64.2 million, up from $57.6 million year-over-year. Gross margin improved to 42.8% from 38.0%. Active providers increased to ~102,000, and total visits rose to ~1.8 million. However, the net loss widened to ($70.3 million), compared to ($39.8 million) last year, while adjusted EBITDA was (47.1 million), up from (26.4 million). Amwell maintains its 2022 revenue guidance of $275 - $285 million.
Amwell (NYSE: AMWL) has appointed Susan Worthy as Chief Marketing Officer. With over 25 years in healthcare marketing, her role involves leading Amwell’s overall marketing strategy to enhance market position and shareholder value. Worthy previously led marketing at Optum, and her expertise is expected to drive growth during a transformative period for the company. She succeeds Mary Modahl, who retires after over a decade at Amwell. The company aims to improve healthcare access via technology and support over 80 million lives through its telehealth platform.
Amwell (NYSE: AMWL), a leader in telehealth, announced participation in key investor conferences. On May 11, 2022, Dr. Ido Schoenberg, CEO, and CFO Bob Shepardson will present at the BofA Healthcare Conference in Las Vegas. They will also participate in the RBC Capital Markets Healthcare Conference in New York City on May 17, 2022, at 2:05 p.m. ET, and at the Needham Virtual Tech and Media Conference on May 19, 2022, at 10:15 a.m. ET. Audio webcasts will be available on their investor relations website.
Amwell (NYSE: AMWL) has expanded its virtual specialty care offerings, introducing Musculoskeletal (MSK) and Dermatology programs. These initiatives cater to healthcare challenges affecting approximately 50% of U.S. adults, focusing on costly musculoskeletal conditions and the shortage of dermatologists. The MSK program aims to improve access to physical therapy and enhance treatment adherence through digital tools. Meanwhile, the Dermatology program provides quick access to care, reducing the average wait time for in-person visits from 35 days to 24 hours for diagnoses.
Amwell (NYSE: AMWL), a leader in telehealth, will report its first-quarter operating results for the period ending March 31, 2022, on May 9, 2022. Following the earnings release, the management team will host a live conference call at 5:00 p.m. ET to discuss results and provide a business update. Investors can access the webcast on the company's website and call in using provided numbers. Amwell connects providers and patients to enhance healthcare delivery, supporting over 80 million lives through partnerships with 2,000 hospitals and 55 health plans.
Amwell (NYSE: AMWL) has announced a shortened earnout period for its acquisition of Conversa Health, which was purchased in August 2021. This strategic move is expected to enhance integration and support new product development, cross-selling opportunities, and operational efficiencies. In coordination, Amwell issued 1,020,964 shares of Class A common stock to Conversa's former stockholders. Amwell's CEO emphasized the seamless integration as a key driver for improved care delivery and innovative healthcare solutions.
Amwell (NYSE: AMWL), a leader in telehealth, announced participation in upcoming investor conferences.
Key events include Cowen’s 42nd Annual Health Care Conference on March 8, 2022, and Keybanc’s Virtual Healthcare Conference on March 22, 2022. Executives Ido Schoenberg, Roy Schoenberg, and Robert Shepardson will represent the company.
Audio webcasts will be accessible on their investor relations website.
Amwell aims to transform healthcare through a comprehensive digital platform, serving over 80 million lives across 55 health plans.